Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Minoxidil and tretinoin together may help hair growth but need more research.

This study observed that topically applied 2% minoxidil solution significantly increased hair counts in men with early male pattern alopecia over 24 weeks, with no serious safety concerns.

Minoxidil helps hair grow, especially in people with mild hair loss.

This study found that minoxidil concentrations at 1, 10, and 100 μg/ml inhibited the proliferation of cultured hair follicle cells without causing morphological changes.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

In this observational study, the combination of PRP and 5% minoxidil was more effective than minoxidil alone in promoting hair growth in men with androgenetic alopecia.

In this correspondence, researchers reported that very-low-dose oral minoxidil (0.25 mg/d) showed some effectiveness in stabilizing trichoscopic parameters in male androgenetic alopecia. However, their analysis suggests that higher doses (2.5–5 mg/d) may lead to better clinical responses with similar rates of adverse events.

Using minoxidil and tretinoin on the skin, along with oral vitamin D, improved hair thickness and density in two girls with woolly hair.

In this study, daily topical minoxidil treatment in neonatal hairless pups led to increased hair growth and the development of hair follicles in the treated areas.

This study found that 3% topical minoxidil decreased hair shedding and promoted hair growth in women with androgenetic alopecia.

This survey found that over 70% of dermatologists in the sample had prescribed topical minoxidil for hair loss, with low reported complications beyond local irritation.

Low-dose oral minoxidil can cause dizziness in women without lowering blood pressure, so careful monitoring is needed.

In this study, combining compound glycyrrhizin with topical minoxidil was more effective and as safe as minoxidil alone for treating alopecia areata.

In a mouse model, this study found that nano-sized molybdenum accelerated hair growth and reduced oxidative stress markers, with enhancements observed when combined with minoxidil. It suggests potential for this combination as a novel topical treatment for hair loss, pending further clinical validation.

This case report identified drug-induced lung disease caused by minoxidil in a patient initially misdiagnosed with hypersensitivity pneumonitis, stressing the need for accurate medication history.

This study found that the p.E402K mutation in the KRT86 gene is a hotspot in Chinese patients with monilethrix, and treatment with 5% topical minoxidil significantly improved hair density and quality.

This study found that combining topical minoxidil with microneedling improved hair density more than either minoxidil alone or with spironolactone for women with mild-to-moderate female pattern hair loss.

In this study, researchers aimed to evaluate the safety and tolerability of low-dose oral minoxidil in adolescents, as existing data on its use in this population are limited and there are no specific pediatric guidelines for prescribing it. Results are not reported.

The study found that growing dermal papilla cells in 3D spheroids enhances their activity with hair growth-promoting agents, such as minoxidil and TCQA, compared to traditional 2D cultures.

This study observed that minoxidil-loaded nanoparticles significantly enhanced skin penetration and hair regrowth in mice within three weeks, without ethanol and propylene glycol, suggesting they are a promising delivery method for treating hair loss.

The researchers reported that combining platelet-rich plasma with minoxidil showed the most improvement in androgenetic alopecia compared to other treatment groups, but also had more pain as a side effect.

This study found that in a mouse model of bronchopulmonary dysplasia, minoxidil administered at 50 mg/kg/day did not impact lung development or inhibit lysyl hydroxylation.

In this randomized controlled study, the researchers found that an herbal extract combination showed similar efficacy to 3% minoxidil solution in treating androgenetic alopecia over 24 weeks, with no significant safety concerns, suggesting it might be a viable alternative treatment.

Choose between topical and oral minoxidil for hair growth based on personal tolerance and side effects.

In this study, microneedling with minoxidil solution showed a significantly better response in treating male androgenetic alopecia compared to microneedling with a hair multivitamin solution.

In this study, researchers found that topical ketoconazole showed delayed hair growth compared to minoxidil in female pattern hair loss but had fewer side effects, though patient satisfaction was similar for both treatments.

This study reported that CoFe2O4 magnetic nanoparticles efficiently catalyzed the synthesis of minoxidil from 2,6-diamino-4-chloro-pyrimidine N-oxide, achieving a 95% yield with sustained reusability.

A woman's use of minoxidil for hair loss caused fluid buildup in her chest, which went away when she stopped using the product.

In this study, Oligonol® was shown to regulate gene expression related to cell proliferation and inflammation in human dermal papilla cells.

This case report suggests that topical minoxidil 5% may cause erectile dysfunction and decreased libido, as observed in a patient whose symptoms improved after discontinuing the medication and recurred upon re-administration.